Wang, Han-I.
Wright, Barry
Tindall, Lucy
Cooper, Cindy
Biggs, Katie
Lee, Ellen
Teare, M. Dawn
Gega, Lina
Scott, Alexander J.
Hayward, Emily
Solaiman, Kiera
Davis, Thompson
McMillan, Dean
Gilbody, Simon
Parrott, Steve
Funding for this research was provided by:
Health Technology Assessment Programme (HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04, HTA15/38/04)
Article History
Received: 31 August 2021
Accepted: 29 July 2022
First Online: 12 August 2022
Declarations
:
: The ethical approval was obtained from North East – York Ethics Research Committee (17/NE/0012). The study was conducted according to the principles of the Declaration of Helsinki (version 2013) and in accordance with other relevant guidelines and regulations. The written informed consent was obtained from parents/guardians, alongside consent or assent from their child. All analyses methods were in line with National Institute for Health and Care Excellence (NICE) guidelines for assessing cost effectiveness, and the results were reported following the Consolidated Health Economic Evaluation Reporting Standards (CHEERS).
: Not applicable.
: Thompson Davis receives royalties from the sale of Intensive One-Session Treatment of specific phobias and fees for training workshops and speaking engagements. The rest of the authors declared no conflicts of interest.